Managing Migraine in the Times of COVID-19 Pandemic.
COVID-19
Coronavirus
migraine
treatment
Journal
Annals of Indian Academy of Neurology
ISSN: 0972-2327
Titre abrégé: Ann Indian Acad Neurol
Pays: India
ID NLM: 101273955
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
12
04
2020
revised:
13
04
2020
accepted:
13
04
2020
entrez:
19
5
2020
pubmed:
19
5
2020
medline:
19
5
2020
Statut:
ppublish
Résumé
COVID-19 pandemic is an emerging, rapidly evolving situation. Migraine is one of the commonest and highly disabling chronic neurological diseases in the world. During the pandemic and lockdown, migraine patients are facing an enormous problem in getting optimum care because of difficulty in access, forced social isolation, and encountering a health system that is getting rapidly overwhelmed. It is important that they must be protected by minimizing their visits to the clinics and emergency departments. Paradoxically multiple triggers are in operation which is likely to increase their headache frequency. Hence physicians should be made aware of the new rules of the game in treating migraines during this time of the pandemic so that these patients get optimum treatment and care and don't feel left out. This review tries to answer a series of questions related to managing migraines in the times of COVID-19 pandemic.
Identifiants
pubmed: 32419752
doi: 10.4103/aian.AIAN_296_20
pii: AIAN-23-33
pmc: PMC7213033
doi:
Types de publication
Journal Article
Langues
eng
Pagination
S33-S39Informations de copyright
Copyright: © 2006 - 2020 Annals of Indian Academy of Neurology.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
Cephalalgia. 2017 Aug;37(9):855-863
pubmed: 27301460
Cephalalgia. 2006 Jun;26(6):684-90
pubmed: 16686907
Nat Rev Neurol. 2016 Aug;12(8):455-64
pubmed: 27389092
Neurol Sci. 2017 May;38(Suppl 1):117-120
pubmed: 28527067
Cephalalgia. 2018 Jul;38(8):1442-1454
pubmed: 29848108
Neurology. 2018 Dec 11;91(24):e2211-e2221
pubmed: 30446596
Travel Med Infect Dis. 2020 Mar - Apr;34:101623
pubmed: 32179124
J Headache Pain. 2019 Jan 16;20(1):6
pubmed: 30651064
Neurology. 2020 Jan 7;94(1):30-38
pubmed: 31801829
Arch Neurol. 1997 Dec;54(12):1506-9
pubmed: 9400360
JAMA Neurol. 2018 Sep 1;75(9):1080-1088
pubmed: 29813147
Neurology. 2018 May 8;90(19):e1702-e1705
pubmed: 29626180
Lancet Neurol. 2017 Jun;16(6):425-434
pubmed: 28460892
Front Neurol. 2019 Mar 19;10:228
pubmed: 30941087
Curr Pain Headache Rep. 2019 Sep 12;23(11):85
pubmed: 31515634
J Headache Pain. 2019 Aug 23;20(1):89
pubmed: 31443629
J Headache Pain. 2015;16:102
pubmed: 26631235
Can J Neurol Sci. 1993 May;20(2):131-7
pubmed: 8334575
Neurology. 2017 Jul 11;89(2):153-162
pubmed: 28615434
N Engl J Med. 2017 Nov 30;377(22):2123-2132
pubmed: 29171821
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
J Headache Pain. 2015;16:67
pubmed: 26197976
N Engl J Med. 2017 Nov 30;377(22):2113-2122
pubmed: 29171818
Headache. 2015 Jan;55(1):1-2
pubmed: 25600717
Neurol Sci. 2010 Oct;31(5):545-53
pubmed: 20614150
JAMA. 2018 May 15;319(19):1999-2008
pubmed: 29800211
Headache. 2020 May;60(5):988-989
pubmed: 32267962
Headache. 2020 May;60(5):833-842
pubmed: 32227596
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Cephalalgia. 2018 May;38(6):1026-1037
pubmed: 29471679